Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.
Acta Oncol. 2002;41(3):276-81. doi: 10.1080/02841860260088827.
Acta Oncol. 2002.
PMID: 12195747
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Margolin S, Bengtsson NO, Carlsson L, Edlund P, Hellstrøm M, Karlsson P, Lidbrink E, Linderholm B, Lindman H, Malmström P, Pettersson Skøld D, Søderberg M, Villman K, Bergh J; Scandinavian Breast Group Study SBG 2004-1.
Margolin S, et al. Among authors: pettersson skold d.
Acta Oncol. 2011 Jan;50(1):35-41. doi: 10.3109/0284186X.2010.535847.
Acta Oncol. 2011.
PMID: 21174610
Clinical Trial.
Item in Clipboard
Cite
Cite